While evidence of aberrant HLA class II expression in the pancreatic islets of patients with type 1 diabetes is increasing [15], hyperexpression of HLA-I antigens in insulin-containing islets (ICIs) is now widely accepted as a defining hallmark of the disease. Here, INS is linked to type 1 diabetes mellitus.